TCBP
Closed
Tc Biopharm Holdings Plc
0.4898
-0.0102 (-2.04%)
Last Update: 17 Apr 2025 16:30:00
Yesterday: 0.5
Day's Range: 0.286 - 0.4899
Send
sign up or login to leave a comment!
When Written:
1.7577
TC BioPharm Holdings PLC is a UK-based biopharmaceutical company that specializes in the development and commercialization of innovative cell therapies for the treatment of cancer and other diseases. The company's core technology platform is based on the use of gamma delta T cells, which are a type of immune cell that can target and kill cancer cells.
TC BioPharm Holdings PLC was founded in 2013 and is headquartered in Edinburgh, Scotland. The company has a strong research and development program, with a focus on advancing its lead product candidate, TCB001, for the treatment of various types of cancer.
TC BioPharm Holdings PLC is listed on the London Stock Exchange under the ticker symbol TCB. The company has a strong management team and a solid financial position, with a market capitalization of around £70 million as of 2021.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
TC BioPharm Holdings PLC was founded in 2013 and is headquartered in Edinburgh, Scotland. The company has a strong research and development program, with a focus on advancing its lead product candidate, TCB001, for the treatment of various types of cancer.
TC BioPharm Holdings PLC is listed on the London Stock Exchange under the ticker symbol TCB. The company has a strong management team and a solid financial position, with a market capitalization of around £70 million as of 2021.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!








